113 results
Page 4 of 6
8-K
EX-1.1
tn97zx q4g
19 Feb 21
Entry into a Material Definitive Agreement
4:13pm
424B5
znsiu62wxrs e5
19 Feb 21
Prospectus supplement for primary offering
4:12pm
8-K
EX-1.1
did53dx
18 Dec 20
ENDRA Life Sciences Announces Proposed Public Offering of Common Stock
5:04pm
424B5
7oilr
17 Dec 20
Prospectus supplement for primary offering
5:17pm
424B5
jeaprbb
15 Dec 20
Prospectus supplement for primary offering
5:04pm
8-K
EX-99.1
hses0pxcc x8vz21
16 Nov 20
ENDRA Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update
4:05pm
8-K
EX-1.1
cmgt0
25 Sep 20
Entry into a Material Definitive Agreement
4:54pm
424B5
m935l6k7
25 Sep 20
Prospectus supplement for primary offering
4:53pm
8-K
EX-99.1
asucevgjzhq4 hpzba
14 May 20
ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results
4:04pm
PRE 14A
jg689y
17 Apr 20
Preliminary proxy
4:18pm
8-K
EX-1.1
lv7xvj6cdfldndz54 hz
27 Mar 20
Entry into a Material Definitive Agreement
5:19pm
424B5
hkd6of
27 Mar 20
Prospectus supplement for primary offering
5:19pm
8-K
EX-99.1
kxclz70qt5hbvfdrkiz
26 Mar 20
ENDRA Life Sciences Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results
4:07pm
8-K
EX-10.1
hs5l5m42pkolv6vz
27 Dec 19
Departure of Directors or Certain Officers
4:06pm
8-K
EX-10.2
6esyccymic8lkvp
27 Dec 19
Departure of Directors or Certain Officers
4:06pm